BriaCell Therapeutics Corporation (BCTX)
NASDAQ
News
Market Data
Register to chat with like-minded investors on our interactive forums.
The current BCTX market cap is 11.79M. The company's latest EPS is USD -1.2918 and P/E is -8.21.
| Quarter End | Jan 2024 | Apr 2024 | Jul 2024 | Oct 2024 | Jan 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -9.85M | -9.27M | -5.88M | -5.22M | -7.21M |
| Net Income | -11.3M | 1.72M | -1.22M | -5.8M | -6.29M |
| Year End July 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -2.95M | -5.55M | -15.29M | -23.27M | -33.44M |
| Net Income | -4.03M | -428k | -26.84M | -20.3M | -4.79M |
| Quarter End | Jan 2024 | Apr 2024 | Jul 2024 | Oct 2024 | Jan 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 12.23M | 6.2M | 5.87M | 10.41M | 9.36M |
| Total Liabilities | 20.55M | 12.44M | 8.56M | 6.7M | 6.14M |
| Total Equity | -8.32M | -6.23M | -2.69M | 3.71M | 3.23M |
| Year End July 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 522k | 58.04M | 42.58M | 27.16M | 5.87M |
| Total Liabilities | 4.12M | 782k | 32.25M | 30.94M | 8.56M |
| Total Equity | -3.6M | 57.26M | 10.33M | -3.78M | -2.69M |
| Quarter End | Jan 2024 | Apr 2024 | Jul 2024 | Oct 2024 | Jan 2025 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -15.01M | -20.09M | -24.13M | -6.96M | -12.88M |
| Investing | N/A | -225k | -682k | -75k | -150k |
| Financing | N/A | N/A | 4.42M | 11.96M | 17.18M |
| Year End July 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -1.27M | -7.75M | -12.48M | -23.75M | -24.13M |
| Investing | N/A | N/A | N/A | N/A | -682k |
| Financing | 1.17M | 64.99M | -3.74M | 3.95M | 4.42M |
| Market Cap | 11.79M |
| Price to Earnings Ratio | -8.21 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 45.61 |
| Price to Book Ratio | -14.64 |
| Dividend Yield | - |
| Shares Outstanding | 3.71M |
| Average Volume (1 week) | 94.8k |
| Average Volume (1 Month) | 775.53k |
| 52 Week Change | -83.44% |
| 52 Week High | 29.40 |
| 52 Week Low | 2.814 |
| Spread (Intraday) | 0.06 (1.89%) |
| Company Name | BriaCell Therapeutics Corporation |
| Address |
suite 300 - 235 west 15th street vancouver, british columbia V7T 2X1 |
| Website | https://www.briacell.com |
| Industry | business services, nec (7389) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
